The Valley Desk

ArticleJournal of internal medicinePublished

Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of internal medicine
Published
Subject terms
Humans; Liver Cirrhosis, Biliary; Liver Cirrhosis; Ursodeoxycholic Acid; Retrospective Studies; COVID-19; SARS-CoV-2; farnesoid X receptor; Udca; Primary Biliary Cholangitis; Covid-19; Sars-cov-2
PubMed ID
37018129
PubMed Central ID
PMC12036735
Added to directory
Source checked

Report a correction or request removal